GB201221032D0 - Method of treatment - Google Patents

Method of treatment

Info

Publication number: GB201221032D0
Authority: GB; United Kingdom
Prior art keywords: treatment
Prior art date: 2012-11-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1221032.4A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

MENS HEALTH Ltd

Original Assignee

MENS HEALTH Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-11-22

Filing date

2012-11-22

Publication date

2013-01-09

2012-11-22 Application filed by MENS HEALTH Ltd filed Critical MENS HEALTH Ltd

2012-11-22 Priority to GBGB1221032.4A priority Critical patent/GB201221032D0/en

2013-01-09 Publication of GB201221032D0 publication Critical patent/GB201221032D0/en

2013-11-21 Priority to PCT/GB2013/000508 priority patent/WO2014080161A1/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Vascular Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GBGB1221032.4A 2012-11-22 2012-11-22 Method of treatment Ceased GB201221032D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB1221032.4A GB201221032D0 (en)	2012-11-22	2012-11-22	Method of treatment
PCT/GB2013/000508 WO2014080161A1 (en)	2012-11-22	2013-11-21	Vip and an alpha-adrenergic blocker for use in the treatment of erectile dysfunction post radical prostatectomy

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1221032.4A GB201221032D0 (en)	2012-11-22	2012-11-22	Method of treatment

Publications (1)

Publication Number	Publication Date
GB201221032D0 true GB201221032D0 (en)	2013-01-09

Family

ID=47560499

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1221032.4A Ceased GB201221032D0 (en)	2012-11-22	2012-11-22	Method of treatment

Country Status (2)

Country	Link
GB (1)	GB201221032D0 (en)
WO (1)	WO2014080161A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5236904A (en) *	1989-09-18	1993-08-17	Senetek, Plc	Erection-inducing methods and compositions
US5447912A (en) *	1989-09-18	1995-09-05	Senetek, Plc	Erection-inducing methods and compositions
ES2270517T3 (en) *	1997-05-19	2007-04-01	Zonagen, Inc.	COMBINATION THERAPY TO MODULATE THE HUMAN SEXUAL RESPONSE.
AU2001281396A1 (en) *	2000-08-08	2002-02-18	The Trustees Of Boston University	Novel compositions and methods for treatment of male erectile dysfunction
EP1865955A4 (en) *	2005-03-25	2009-04-15	Merck & Co Inc	Method of treating men with testosterone supplement and 5alpha-reductase inhibitor
EP2324886A1 (en) *	2005-07-29	2011-05-25	Concert Pharmaceuticals Inc.	Novel deuterated analogues of tadalafil

2012
- 2012-11-22 GB GBGB1221032.4A patent/GB201221032D0/en not_active Ceased
2013
- 2013-11-21 WO PCT/GB2013/000508 patent/WO2014080161A1/en active Application Filing

Also Published As

Publication number	Publication date
WO2014080161A1 (en)	2014-05-30

Publication	Publication Date	Title
GB201110095D0 (en)	2011-07-27	Method of treatment
EP2773754A4 (en)	2015-06-10	Method of treatment
EP2723384A4 (en)	2015-08-12	Treatment of proteinopathies
EP2717855A4 (en)	2014-11-12	Methods of treatment
HK1210962A1 (en)	2016-05-13	Methods for treatment of atherosclerosis
EP2895206A4 (en)	2016-05-04	Method of treating cancer
HK1203370A1 (en)	2015-10-30	Method for treatment of labor arrest
HK1216504A1 (en)	2016-11-18	Method for treatment of diseases
EP2884975A4 (en)	2016-04-13	Method of treating onychomycosis
IL241096B (en)	2021-05-31	Method of treatment
EP2812338A4 (en)	2015-09-23	Method of treatment of nasopharyngeal caner
GB201215942D0 (en)	2012-10-24	Method of treatent
EP2791324A4 (en)	2015-04-29	Method of treatment
GB201221032D0 (en)	2013-01-09	Method of treatment
GB201207894D0 (en)	2012-06-20	Method of treatment
GB201221118D0 (en)	2013-01-09	Methods of treatment
GB201216740D0 (en)	2012-10-31	Methods of treatment
GB201216748D0 (en)	2012-10-31	Methods of treatment
GB201206326D0 (en)	2012-05-23	Methods of treatment
GB201206324D0 (en)	2012-05-23	Methods of treatment
GB201206330D0 (en)	2012-05-23	Methods of treatment
GB201206325D0 (en)	2012-05-23	Methods of treatment
EP2911662A4 (en)	2016-09-28	Method of treatment of disease
GB201111530D0 (en)	2011-08-17	Method of treatment
GB201109509D0 (en)	2011-07-20	Method of treatment

Legal Events

Date	Code	Title	Description
2014-07-16	AT	Applications terminated before publication under section 16(1)